| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 132.922 | 114.366 | 123.033 | 148.381 | 191.827 | 224.072 | 216.768 | 326.749 | 319.075 | 337.359 |
| Total Income - EUR | 134.790 | 114.642 | 123.033 | 148.652 | 191.827 | 224.072 | 216.768 | 327.757 | 321.784 | 338.204 |
| Total Expenses - EUR | 132.582 | 112.113 | 117.037 | 164.126 | 189.930 | 214.758 | 202.179 | 325.484 | 356.879 | 354.869 |
| Gross Profit/Loss - EUR | 2.208 | 2.529 | 5.996 | -15.474 | 1.897 | 9.314 | 14.589 | 2.273 | -35.095 | -16.664 |
| Net Profit/Loss - EUR | 1.802 | 1.852 | 2.670 | -16.962 | 60 | 7.170 | 12.465 | -512 | -38.332 | -26.907 |
| Employees | 3 | 4 | 3 | 4 | 4 | 2 | 3 | 4 | 3 | 4 |
Check the financial reports for the company - Anaderol Trans Family S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.505 | 9.576 | 5.409 | 5.558 | 5.014 | 4.305 | 4.980 | 42.070 | 34.791 | 23.491 |
| Current Assets | 21.890 | 38.891 | 41.804 | 41.028 | 55.758 | 42.690 | 55.379 | 85.840 | 34.815 | 36.673 |
| Inventories | 566 | 3.547 | 13.743 | 8.162 | 10.531 | 9.840 | 20.257 | 28.106 | 3.422 | 1.625 |
| Receivables | 13.644 | 19.478 | 18.856 | 14.261 | 38.717 | 27.737 | 26.883 | 45.013 | 38.572 | 29.324 |
| Cash | 7.679 | 15.866 | 9.205 | 18.606 | 6.509 | 5.113 | 8.238 | 12.721 | -7.179 | 5.724 |
| Shareholders Funds | 8.259 | 10.027 | 12.527 | -7.285 | -7.084 | 220 | 12.680 | 12.208 | -26.161 | -52.922 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 28.135 | 38.440 | 34.687 | 53.872 | 67.856 | 46.776 | 47.680 | 115.702 | 95.767 | 113.086 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Anaderol Trans Family S.r.l.